Sage Therapeutics, Inc. - COM (SAGE)

Historical Portfolio Holders from Q3 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
56.7 M
Holdings value Q1 2024
$1.06 B
Value change Q1 2024
+$31.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
191
Number of buys Q1 2024
91
Number of sells Q1 2024
-81
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
78667J108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 56.7 M $1.06 B +$31.2 M $18.74 191
2023 Q4 54.8 M $1.19 B -$81.8 M $21.67 193
2023 Q3 57.8 M $1.19 B -$2.92 M $20.58 188
2023 Q2 53.3 M $2.51 B +$37.8 M $47.02 217
2023 Q1 52.6 M $2.21 B +$61.6 M $41.96 207
2022 Q4 51.3 M $1.96 B +$2.02 M $38.14 197
2022 Q3 44.4 M $1.74 B +$7.13 M $39.16 178
2022 Q2 50.3 M $1.62 B +$35.1 M $32.30 181
2022 Q1 49.3 M $1.63 B -$34.5 M $33.10 184
2021 Q4 44.6 M $1.9 B +$38.9 M $42.54 194
2021 Q3 49 M $2.17 B -$111 M $44.31 216
2021 Q2 50.4 M $2.86 B -$183 M $56.81 251
2021 Q1 53.1 M $3.97 B -$90.5 M $74.85 255
2020 Q4 53.4 M $4.62 B +$45.1 M $86.51 236
2020 Q3 53.5 M $3.27 B -$23.4 M $61.12 217
2020 Q2 53.6 M $2.23 B +$1.23 M $41.58 202
2020 Q1 54.9 M $1.58 B -$221 M $28.72 207
2019 Q4 55.5 M $4.01 B -$406 M $72.19 251
2019 Q3 58.1 M $8.15 B +$20.7 M $140.29 269
2019 Q2 58 M $10.6 B +$1.07 B $183.09 262
2019 Q1 55.8 M $8.88 B +$1.1 B $159.05 255
2018 Q4 49.7 M $4.76 B +$6.32 M $95.79 238
2018 Q3 48.7 M $6.87 B +$63.1 M $141.25 268
2018 Q2 48.4 M $7.57 B +$240 M $156.53 259
2018 Q1 47.4 M $7.63 B +$643 M $161.07 242
2017 Q4 44 M $7.25 B +$674 M $164.71 219
2017 Q3 39.3 M $2.45 B +$48.6 M $62.30 175
2017 Q2 38.4 M $3.05 B +$15.1 M $79.64 189
2017 Q1 37.9 M $2.69 B +$271 M $71.07 189
2016 Q4 36.7 M $1.87 B -$47.8 M $51.06 159
2016 Q3 37.7 M $1.73 B +$399 M $46.05 149
2016 Q2 30.2 M $911 M +$29 M $30.13 142
2016 Q1 29.1 M $932 M +$174 M $32.06 137
2015 Q4 23.5 M $1.37 B +$159 M $58.30 133
2015 Q3 27.2 M $1.15 B +$22.8 M $42.32 125
2015 Q2 26.3 M $1.92 B +$371 M $73.00 120
2015 Q1 21.5 M $1.08 B +$66.6 M $50.23 89
2014 Q4 19.7 M $721 M +$20.8 M $36.60 70
2014 Q3 18.9 M $595 M +$595 M $31.50 50